Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating human disease.

The most complex engineering of human cell lines ever has been achieved by scientists, revealing that our genomes are more resilient to significant structural changes than was previously thought.

Visualizing cells after editing specific genes can help scientists learn new details about the function of those genes. But ...

CRISPR Therapeutics' stock decline is likely influenced by Editas Medicine's struggles, but CRISPR remains a distinct and stronger company with a promising long-term outlook. CRISPR's strategic ...

These patterns are the basis of a primitive immune system that bacteria use to ‘remember’ the DNA of viral invaders by incorporating the DNA sequence of the virus within the CRISPR patterns. The Cas9 ...

Ductal carcinoma in situ is a precursor of breast cancer that is usually treated with surgery, radiation therapy, and estrogen blockade. A new study suggests that watchful waiting might be safe for ...

Two decades later, thanks to massive improvements in gene sequencing and synthesis technologies alongside the rise of gene editing multitool CRISPR, gene therapy is no longer science fiction. In late ...

School of Materials Science and Engineering, Wuhan University of Technology, Wuhan 430070, China State Key Laboratory of Silicate Materials for Architectures, Wuhan University of Technology, Wuhan ...

We recently compiled a list of the Top 11 CRISPR Stocks to Invest In. In this article, we are going to take a look at where Pacific Biosciences of California, Inc. (NASDAQ:PACB) stands against the ...

CAS Key Laboratory of Nanosystem and Hierarchical Fabrication, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, CAS, Beijing 100190, China ...